ERD

Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic compli...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multic...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 O...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to mo...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

A retrospective study assessing the characteristics of COVID‐19 convalescent plasma donors and donations

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: ...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsivene...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Impact of Viral Decontamination Method on Cytokine Profile of COVID-19 Patients

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the inf...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of ...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as ...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Evolution of antibody immunity to SARS-CoV-2

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Mucosal IgA against SARS-CoV-2 Omicron Infection

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-1...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technolog...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection...

Project: ATAC

Updated at: 31-10-2023

Show more information

Project acronym ATAC

Resources

Selected filters:

Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic compli...

Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area

Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multic...

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 O...

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to mo...

A retrospective study assessing the characteristics of COVID‐19 convalescent plasma donors and donations

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

SARS-CoV-2–specific B- and T-cell immunity in a population-based study of young Swedish adults

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: ...

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsivene...

Impact of Viral Decontamination Method on Cytokine Profile of COVID-19 Patients

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses

ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the inf...

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of ...

Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as ...

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies

Evolution of antibody immunity to SARS-CoV-2

Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice

Mucosal IgA against SARS-CoV-2 Omicron Infection

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-1...

Adapting Neutralizing Antibodies to Viral Variants by Structure-Guided Affinity Maturation Using Phage Display Technolog...

The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.

Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection...